Validation of Handheld Ultrasound Devices in Rheumatology
1 other identifier
observational
30
2 countries
3
Brief Summary
The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2023
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2024
CompletedFirst Submitted
Initial submission to the registry
August 27, 2024
CompletedFirst Posted
Study publicly available on registry
August 30, 2024
CompletedAugust 30, 2024
August 1, 2024
1.4 years
August 27, 2024
August 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraarticular synovitis scoring
After the imaging of all patients is completed, intraarticular synovitis scoring will be done based on the OMERACT definitions (scales of 0-3) as follows. Greyscale inflammatory (hypoechoic) synovial hyperplasia: Grade 0: no hypoechoic synovial hyperplasia Grade 1: minimal hypoechoic synovial hyperplasia (filling the angle between the periarticular bones, without bulging over the line linking tops of the bones) Grade 2: hypoechoic synovial hyperplasia bulging over the line linking tops of the periarticular bones but without extension along the bone diaphysis Grade 3: hypoechoic synovial hyperplasia bulging over the line linking tops of the periarticular bones and with extension to at least one of the bone diaphysis
6 months
Secondary Outcomes (4)
Intraarticular Doppler scoring
6 months
Assessment of nail images
6 months
Assessment of tendon images
6 months
Assessment of entheses images
6 months
Other Outcomes (1)
Adverse event
6 months
Study Arms (1)
Psoriatic arthritis
Age ≥18, Meets the classification for psoriatic arthritis (CASPAR) criteria, Able to provide an informed consent, Having peripheral disease phenotype of PsA, At least one tender and swollen join on the day of US
Interventions
All patients having ultrasound with Clarius L15/L20 and GE logic E9/E10 in same visit.
Eligibility Criteria
Patient who fulfilled the inclusion and exclusion criterion.
You may qualify if:
- Age ≥18
- Meets the classification for psoriatic arthritis (CASPAR) criteria
- Able to provide an informed consent
- Having peripheral disease phenotype of PsA
- At least one tender and swollen join on the day of US
You may not qualify if:
- Having isolated axial PsA
- Being in MDA with no tender and swollen joints
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ottawa Hospital Research Institutelead
- University of Floridacollaborator
- University Health Network, Torontocollaborator
- Novartiscollaborator
Study Sites (3)
University of Florida College of Medicine
Gainesville, Florida, 32610, United States
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6, Canada
Women's College Research Institute
Toronto, Ontario, M5S 1B2, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sibel Z Aydin, Prof
Ottawa Hospital Research Institute
- PRINCIPAL INVESTIGATOR
Lihi Eder, Prof
Women's College Hospital
- PRINCIPAL INVESTIGATOR
Gurjit Kaeley, Prof
University of Florida
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 27, 2024
First Posted
August 30, 2024
Study Start
January 16, 2023
Primary Completion
June 28, 2024
Study Completion
June 28, 2024
Last Updated
August 30, 2024
Record last verified: 2024-08